Psychologists in Moriarty, NM Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Toby Hurtado Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 200 Center Street, Moriarty, NM 87035 Phone: 505-832-5817 Fax: 505-832-5918 |
 Richard Eaton, M.S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 200 Center Street, Moriarty, NM 87035 Phone: 505-832-4471 |
Sunny Klempel Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: Po Box 2000, Moriarty, NM 87035 Phone: 505-832-5725 |
Dr. Craig S Nettleton, PE.D. PSYCHOLOGY Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 200 Center Street, Moriarty, NM 87035 Phone: 505-832-5817 Fax: 505-832-5918 |
Mrs. Tammy Ann Eastham, ED. S. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 200 Center St, Moriarty, NM 87035 Phone: 505-832-4421 Fax: 505-832-4472 |
News Archive
Momenta prices underwritten public offering
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.
CytRx granted European patent for tumor-targeting linker platform technology
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that the European Patent Office (EPO) has issued a patent covering the Company's tumor-targeting linker platform technology and pharmaceutical compositions.
Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma
Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.
Researchers unravel mechanism behind sickle hemoglobin protection against malaria
The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ci-ncia, in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection.
› Verified 1 days ago